BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1099 hits of ic50 data for polymerid = 50006155   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kcal/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538576
PNG
(CHEMBL4634092)
Show SMILES Cc1cc(Cl)cc(c1C[C@@H]1CNCCO1)-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12 |r|
Show InChI InChI=1S/C25H24ClN3O3S/c1-13-6-14(26)7-19(18(13)8-15-11-27-4-5-32-15)17-2-3-28-22-9-16(33-23(17)22)12-29-24(30)20-10-21(20)25(29)31/h2-3,6-7,9,15,20-21,27H,4-5,8,10-12H2,1H3/t15-,20?,21?/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.160n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538560
PNG
(CHEMBL4640002)
Show SMILES Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)C(=O)N1CCNCC1 |r|
Show InChI InChI=1S/C25H23ClN4O4S/c26-15-9-14-10-20(25(33)29-7-5-27-6-8-29)34-23(14)18(11-15)17-3-4-28-19-12-16(35-24(17)19)13-30-21(31)1-2-22(30)32/h3-4,9,11-12,20,27H,1-2,5-8,10,13H2/t20-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
n/an/a 0.180n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair		3D
3D Structure (crystal)
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538571
PNG
(CHEMBL4635160)
Show SMILES C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12 |r|
Show InChI InChI=1S/C28H30ClN3O3S/c1-14-9-16(29)10-19(24(14)35-21-6-7-30-12-15(21)2)18-5-8-31-20-11-17(36-25(18)20)13-32-26(33)22-23(27(32)34)28(22,3)4/h5,8-11,15,21-23,30H,6-7,12-13H2,1-4H3/t15-,21+,22?,23?/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.180n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538572
PNG
(CHEMBL4649132)
Show SMILES C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(Cn3c(=O)ccn(CC(F)(F)F)c3=O)sc12 |r|
Show InChI InChI=1S/C27H26ClF3N4O3S/c1-15-9-17(28)10-20(24(15)38-22-4-6-32-12-16(22)2)19-3-7-33-21-11-18(39-25(19)21)13-35-23(36)5-8-34(26(35)37)14-27(29,30)31/h3,5,7-11,16,22,32H,4,6,12-14H2,1-2H3/t16-,22+/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.260n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538575
PNG
(CHEMBL4638458)
Show SMILES C[C@H]1CNC[C@H](C)N1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C26H29ClN4O2S/c1-15-8-18(27)9-21(22(15)14-30-16(2)11-28-12-17(30)3)20-6-7-29-23-10-19(34-26(20)23)13-31-24(32)4-5-25(31)33/h6-10,16-17,28H,4-5,11-14H2,1-3H3/t16-,17-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.320n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538562
PNG
(CHEMBL4643330)
Show SMILES Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)c1onc2CCNCc12 |r|
Show InChI InChI=1S/C26H21ClN4O4S/c27-14-7-13-8-21(25-18-11-28-5-4-19(18)30-35-25)34-24(13)17(9-14)16-3-6-29-20-10-15(36-26(16)20)12-31-22(32)1-2-23(31)33/h3,6-7,9-10,21,28H,1-2,4-5,8,11-12H2/t21-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.380n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538578
PNG
(CHEMBL4640729)
Show SMILES C[C@@H]1CNC[C@@H](Cc2c(C)cc(Cl)cc2-c2ccnc3cc(CN4C(=O)C5CC5C4=O)sc23)O1 |r|
Show InChI InChI=1S/C26H26ClN3O3S/c1-13-5-15(27)6-20(19(13)7-16-11-28-10-14(2)33-16)18-3-4-29-23-8-17(34-24(18)23)12-30-25(31)21-9-22(21)26(30)32/h3-6,8,14,16,21-22,28H,7,9-12H2,1-2H3/t14-,16-,21?,22?/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.390n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538579
PNG
(CHEMBL4647217)
Show SMILES Cc1cc(Cl)cc(c1C[C@@H]1CNCCO1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12 |r|
Show InChI InChI=1S/C27H28ClN3O3S/c1-14-8-15(28)9-20(19(14)10-16-12-29-6-7-34-16)18-4-5-30-21-11-17(35-24(18)21)13-31-25(32)22-23(26(31)33)27(22,2)3/h4-5,8-9,11,16,22-23,29H,6-7,10,12-13H2,1-3H3/t16-,22?,23?/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.440n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538582
PNG
(CHEMBL4638998)
Show SMILES Cc1cc(Cl)cc(c1NC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12
Show InChI InChI=1S/C27H29ClN4O2S/c1-14-9-15(28)10-19(23(14)31-16-5-4-7-29-12-16)18-6-8-30-20-11-17(35-24(18)20)13-32-25(33)21-22(26(32)34)27(21,2)3/h6,8-11,16,21-22,29,31H,4-5,7,12-13H2,1-3H3
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.780n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538570
PNG
(CHEMBL4638573)
Show SMILES C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12 |r|
Show InChI InChI=1S/C26H26ClN3O3S/c1-13-7-15(27)8-18(23(13)33-22-4-5-28-11-14(22)2)17-3-6-29-21-9-16(34-24(17)21)12-30-25(31)19-10-20(19)26(30)32/h3,6-9,14,19-20,22,28H,4-5,10-12H2,1-2H3/t14-,19?,20?,22+/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.10n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538563
PNG
(CHEMBL4648116)
Show SMILES Cn1nc2CCNCc2c1[C@H]1Cc2cc(Cl)cc(c2O1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C27H24ClN5O3S/c1-32-25(19-12-29-6-5-20(19)31-32)22-9-14-8-15(28)10-18(26(14)36-22)17-4-7-30-21-11-16(37-27(17)21)13-33-23(34)2-3-24(33)35/h4,7-8,10-11,22,29H,2-3,5-6,9,12-13H2,1H3/t22-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.10n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538564
PNG
(CHEMBL4641569)
Show SMILES Cc1cc(Cl)cc(c1O[C@@H]1CNC[C@@H]1F)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C23H21ClFN3O3S/c1-12-6-13(24)7-16(22(12)31-19-10-26-9-17(19)25)15-4-5-27-18-8-14(32-23(15)18)11-28-20(29)2-3-21(28)30/h4-8,17,19,26H,2-3,9-11H2,1H3/t17-,19+/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
n/an/a 1.20n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair		3D
3D Structure (crystal)
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538583
PNG
(CHEMBL4643112)
Show SMILES Cc1cc(Cl)cc(c1CC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12
Show InChI InChI=1S/C28H30ClN3O2S/c1-15-9-17(29)11-21(20(15)10-16-5-4-7-30-13-16)19-6-8-31-22-12-18(35-25(19)22)14-32-26(33)23-24(27(32)34)28(23,2)3/h6,8-9,11-12,16,23-24,30H,4-5,7,10,13-14H2,1-3H3
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.30n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538577
PNG
(CHEMBL4648623)
Show SMILES C[C@H]1NCCO[C@@H]1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4CC4C3=O)sc12 |r|
Show InChI InChI=1S/C26H26ClN3O3S/c1-13-7-15(27)8-19(18(13)11-23-14(2)28-5-6-33-23)17-3-4-29-22-9-16(34-24(17)22)12-30-25(31)20-10-21(20)26(30)32/h3-4,7-9,14,20-21,23,28H,5-6,10-12H2,1-2H3/t14-,20?,21?,23-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.5n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50465231
PNG
(CHEMBL4288150 | US10766903, Example 30)
Show SMILES C[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CN)cc4)n(C)nc3c2=O)CC1)c1ccccc1 |r|
Show InChI InChI=1S/C29H34N6O3/c1-20(22-6-4-3-5-7-22)16-24(36)34-14-12-29(38,13-15-34)18-35-19-31-25-26(28(35)37)32-33(2)27(25)23-10-8-21(17-30)9-11-23/h3-11,19-20,38H,12-18,30H2,1-2H3/t20-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem
n/an/a 1.5n/an/an/an/an/an/a


TBA



Citation and Details
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538567
PNG
(CHEMBL4633860)
Show SMILES Cc1cc(Cl)cc(c1OCC1(F)CNC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12
Show InChI InChI=1S/C23H21ClFN3O3S/c1-13-6-14(24)7-17(21(13)31-12-23(25)10-26-11-23)16-4-5-27-18-8-15(32-22(16)18)9-28-19(29)2-3-20(28)30/h4-8,26H,2-3,9-12H2,1H3
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.5n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		CHEMBL5281187
PNG
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
UniChem
n/an/a 1.5n/an/an/an/an/an/a


TBA



Citation and Details
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50514118
PNG
(CHEMBL4590454)
Show SMILES Cn1nc2c(ncn(CC3(O)CCN(CC3)C(=O)C[C@H](c3ccccc3)C(F)(F)F)c2=O)c1Cc1ccc(CN)cc1 |r|
Show InChI InChI=1S/C30H33F3N6O3/c1-37-24(15-20-7-9-21(17-34)10-8-20)26-27(36-37)28(41)39(19-35-26)18-29(42)11-13-38(14-12-29)25(40)16-23(30(31,32)33)22-5-3-2-4-6-22/h2-10,19,23,42H,11-18,34H2,1H3/t23-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 1.5n/an/an/an/an/an/a



Dana-Farber Cancer Institute

Curated by ChEMBL


Assay Description
Inhibition of USP7 (unknown origin) using Ub-Rh110 substrate

J Med Chem 63: 2731-2750 (2020)


Article DOI: 10.1021/acs.jmedchem.9b01138
BindingDB Entry DOI: 10.7270/Q2GF0XTC
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538569
PNG
(CHEMBL4644317)
Show SMILES C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C25H26ClN3O3S/c1-14-9-16(26)10-19(24(14)32-21-6-7-27-12-15(21)2)18-5-8-28-20-11-17(33-25(18)20)13-29-22(30)3-4-23(29)31/h5,8-11,15,21,27H,3-4,6-7,12-13H2,1-2H3/t15-,21+/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.10n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538581
PNG
(CHEMBL4642862)
Show SMILES Cc1cc(Cl)cc(c1OC1CCCNC1)-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12
Show InChI InChI=1S/C27H28ClN3O3S/c1-14-9-15(28)10-19(23(14)34-16-5-4-7-29-12-16)18-6-8-30-20-11-17(35-24(18)20)13-31-25(32)21-22(26(31)33)27(21,2)3/h6,8-11,16,21-22,29H,4-5,7,12-13H2,1-3H3
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538568
PNG
(CHEMBL4640563)
Show SMILES Cc1cc(Cl)cc(c1O[C@H]1C[C@H](N)C1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r,wU:9.9,wD:11.12,(39.39,-38.53,;38.06,-37.76,;36.71,-38.54,;35.38,-37.77,;34.03,-38.54,;35.38,-36.22,;36.71,-35.44,;38.05,-36.21,;39.38,-35.44,;40.72,-36.2,;42.2,-35.79,;42.6,-37.28,;43.94,-38.04,;41.12,-37.68,;36.7,-33.9,;38.04,-33.13,;38.04,-31.58,;36.69,-30.81,;35.35,-31.6,;33.88,-31.14,;32.99,-32.39,;31.45,-32.4,;30.69,-33.74,;29.16,-33.91,;28.12,-32.78,;28.85,-35.42,;30.19,-36.18,;31.33,-35.14,;32.84,-35.45,;33.91,-33.62,;35.36,-33.14,)|
Show InChI InChI=1S/C23H22ClN3O3S/c1-12-6-13(24)7-18(22(12)30-15-8-14(25)9-15)17-4-5-26-19-10-16(31-23(17)19)11-27-20(28)2-3-21(27)29/h4-7,10,14-15H,2-3,8-9,11,25H2,1H3/t14-,15-
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 3.40n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538565
PNG
(CHEMBL4635798)
Show SMILES Cc1cc(Cl)cc(c1O[C@H]1CCCNC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C24H24ClN3O3S/c1-14-9-15(25)10-19(23(14)31-16-3-2-7-26-12-16)18-6-8-27-20-11-17(32-24(18)20)13-28-21(29)4-5-22(28)30/h6,8-11,16,26H,2-5,7,12-13H2,1H3/t16-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 4.60n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50465231
PNG
(CHEMBL4288150 | US10766903, Example 30)
Show SMILES C[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CN)cc4)n(C)nc3c2=O)CC1)c1ccccc1 |r|
Show InChI InChI=1S/C29H34N6O3/c1-20(22-6-4-3-5-7-22)16-24(36)34-14-12-29(38,13-15-34)18-35-19-31-25-26(28(35)37)32-33(2)27(25)23-10-8-21(17-30)9-11-23/h3-11,19-20,38H,12-18,30H2,1-2H3/t20-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem
Article
PubMed
n/an/a 6n/an/an/an/an/an/a



Almac Discovery Ltd.

Curated by ChEMBL


Assay Description
Inhibition of USP7 (unknown origin) by biochemical assay

ACS Med Chem Lett 9: 238-243 (2018)


Article DOI: 10.1021/acsmedchemlett.7b00512
BindingDB Entry DOI: 10.7270/Q2Q81GRX
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538574
PNG
(CHEMBL4638688)
Show SMILES C[C@H]1CNCCN1Cc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)CCC3=O)sc12 |r|
Show InChI InChI=1S/C25H27ClN4O2S/c1-15-9-17(26)10-20(21(15)14-29-8-7-27-12-16(29)2)19-5-6-28-22-11-18(33-25(19)22)13-30-23(31)3-4-24(30)32/h5-6,9-11,16,27H,3-4,7-8,12-14H2,1-2H3/t16-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 6.60n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50602285
PNG
(CHEMBL5182862)
Show SMILES CNCc1ccc(cc1)-c1n(C)nc2c1ncn(CC1(O)CCN(Cc3ccc(cc3Cl)-c3ccco3)CC1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 7.60n/an/an/an/an/an/a


TBA



Citation and Details

Article DOI: 10.1021/acs.jmedchem.2c01444
BindingDB Entry DOI: 10.7270/Q2WW7NR1
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538566
PNG
(CHEMBL4632475)
Show SMILES Cc1cc(Cl)cc(c1OC1CCNCC1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12
Show InChI InChI=1S/C24H24ClN3O3S/c1-14-10-15(25)11-19(23(14)31-16-4-7-26-8-5-16)18-6-9-27-20-12-17(32-24(18)20)13-28-21(29)2-3-22(28)30/h6,9-12,16,26H,2-5,7-8,13H2,1H3
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 8n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50602291
PNG
(CHEMBL5200808)
Show SMILES Cl.Cl.Cn1nc2c(ncn(CC3(O)CCN(Cc4ccc(cc4Cl)-c4ccco4)CC3)c2=O)c1-c1ccc(CNCCO)cc1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 8.20n/an/an/an/an/an/a


TBA



Citation and Details

Article DOI: 10.1021/acs.jmedchem.2c01444
BindingDB Entry DOI: 10.7270/Q2WW7NR1
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538556
PNG
(CHEMBL4646914)
Show SMILES OCC(O)(CCl)c1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1 |r|
Show InChI InChI=1S/C23H23Cl2N3O4S/c24-11-23(31,12-29)19-10-17-21(33-19)15(1-2-27-17)16-9-14(25)7-13-8-18(32-20(13)16)22(30)28-5-3-26-4-6-28/h1-2,7,9-10,18,26,29,31H,3-6,8,11-12H2/t18-,23?/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 9n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50538561
PNG
(CHEMBL4642308)
Show SMILES Clc1cc2C[C@@H](Oc2c(c1)-c1ccnc2cc(CN3C(=O)CCC3=O)sc12)c1ocnc1CN1CCC1 |r|
Show InChI InChI=1S/C27H23ClN4O4S/c28-16-8-15-9-22(26-21(30-14-35-26)13-31-6-1-7-31)36-25(15)19(10-16)18-4-5-29-20-11-17(37-27(18)20)12-32-23(33)2-3-24(32)34/h4-5,8,10-11,14,22H,1-3,6-7,9,12-13H2/t22-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 13n/an/an/an/an/an/a



RAPT Therapeutics, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...

J Med Chem 63: 5398-5420 (2020)


Article DOI: 10.1021/acs.jmedchem.0c00245
BindingDB Entry DOI: 10.7270/Q2XK8K2T
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50602287
PNG
(CHEMBL5184307)
Show SMILES Cl.Cl.CCNCc1ccc(cc1)-c1n(C)nc2c1ncn(CC1(O)CCN(Cc3ccc(cc3Cl)-c3ccco3)CC1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 15n/an/an/an/an/an/a


TBA



Citation and Details

Article DOI: 10.1021/acs.jmedchem.2c01444
BindingDB Entry DOI: 10.7270/Q2WW7NR1
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50465231
PNG
(CHEMBL4288150 | US10766903, Example 30)
Show SMILES C[C@H](CC(=O)N1CCC(O)(Cn2cnc3c(-c4ccc(CN)cc4)n(C)nc3c2=O)CC1)c1ccccc1 |r|
Show InChI InChI=1S/C29H34N6O3/c1-20(22-6-4-3-5-7-22)16-24(36)34-14-12-29(38,13-15-34)18-35-19-31-25-26(28(35)37)32-33(2)27(25)23-10-8-21(17-30)9-11-23/h3-11,19-20,38H,12-18,30H2,1-2H3/t20-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem
Article
PubMed
n/an/a 18n/an/an/an/an/an/a


TBA



Citation and Details

Article DOI: 10.1021/acs.jmedchem.2c01444
BindingDB Entry DOI: 10.7270/Q2WW7NR1
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM50602280
PNG
(CHEMBL5180062)
Show SMILES Cl.Cl.Cn1nc2c(ncn(CC3(O)CCN(Cc4ccc(cc4Cl)-c4ccco4)CC3)c2=O)c1-c1ccc(CN)cc1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 18n/an/an/an/an/an/a


TBA



Citation and Details

Article DOI: 10.1021/acs.jmedchem.2c01444
BindingDB Entry DOI: 10.7270/Q2WW7NR1
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM507637
PNG
(1-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[[4-hydroxy...)
Show SMILES OC1(Cn2cnc3n(ncc3c2=O)-c2ccc3OCCOc3c2)CCN(CC1)C(=O)[C@@H]1CCNC[C@H]1c1ccccc1 |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 19.6n/an/an/an/an/an/a


TBA

Assay Description
USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2TQ64P6
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581899
PNG
(WO2023003973, Compound 33)
Show SMILES CN(C)CC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)C(CCCNC(=O)c1ccc3c(Cl)c4CN(CCc4nc3c1)C(C)=O)Cc1ccccc1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581900
PNG
(WO2023003973, Compound 41)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@H](CCCNC(=O)c1ccc3c(Cl)c4CCN(C)Cc4nc3c1)Cc1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581901
PNG
(WO2023003973, Compound 49)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)C(CCCNC(=O)c1ccc3c(Cl)cc(C)nc3c1)Cc1ccccc1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581902
PNG
(WO2023003973, Compound 75)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@@H]1CCN(CCNC(=O)c3ccc4c(Cl)ccnc4c3)C[C@H]1c1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581903
PNG
(WO2023003973, Compound 78)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)C(CCCNC(=O)c1ccc3c(Cl)ccnc3c1)Cc1ccccc1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581905
PNG
(WO2023003973, Compound 87)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)C(CCCNC(=O)c1ccc3c(F)ccnc3c1)Cc1ccccc1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581906
PNG
(WO2023003973, Compound 93)
Show SMILES CN1CCN(CCC(=O)Nc2ccc3c(c2)ncn(CC2(O)CCN(CC2)C(=O)C2CCN(C[C@H]2c2ccccc2)c2ccccc2NS(=O)(=O)C=C)c3=O)CC1 |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581907
PNG
(WO2023003973, Compound 106)
Show SMILES CN1CCN(CCC(=O)Nc2ccc3c(c2)ncn(CC2(O)CCN(CC2)C(=O)C2CCN(CC2c2ccccc2)c2cnccc2NC(=O)C=C)c3=O)CC1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581908
PNG
(WO2023003973, Compound 108)
Show SMILES CC(C)c1cnc2cc(ccc2c1Cl)C(=O)NCCN1CCC(C(C1)c1ccccc1)C(=O)N1CCC(O)(Cn2cnc3cc(OCCN4CCNCC4)ccc3c2=O)CC1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581909
PNG
(WO2023003973, Compound 109)
Show SMILES OC1(Cn2cnc3cc(OCCN4CCNCC4)ccc3c2=O)CCN(CC1)C(=O)C1CCN(CCNC(=O)c2ccc3c(F)ccnc3c2)CC1c1ccccc1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581910
PNG
(WO2023003973, Compound 114)
Show SMILES CN(C)CCC(=O)Nc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@H](CCCNC(=O)c1ccc3c(Cl)c4CCCc4nc3c1)Cc1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581911
PNG
(WO2023003973, Compound 116)
Show SMILES CN(C)CCCOc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)C(CCCNC(=O)c1ccc3c(Cl)cc(nc3c1)C1CC1)Cc1ccccc1)c2=O
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581912
PNG
(WO2023003973, Compound 119)
Show SMILES CC(C)c1cnc2cc(ccc2c1Cl)C(=O)NCCC[C@H](Cc1ccccc1)C(=O)N1CCC(O)(Cn2cnc3cc(NC(=O)CCN(C)C)ccc3c2=O)CC1 |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581913
PNG
(WO2023003973, Compound 120)
Show SMILES CC(C)c1cc(Cl)c2ccc(cc2n1)C(=O)NCCC[C@H](Cc1ccccc1)C(=O)N1CCC(O)(Cn2cnc3cc(OCCCN(C)C)ccc3c2=O)CC1 |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581914
PNG
(WO2023003973, Compound 121)
Show SMILES CN(C)CCCOc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@H](CCCNC(=O)c1ccc3c(Cl)c4CC(C)(C)Cc4nc3c1)Cc1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581915
PNG
(WO2023003973, Compound 123)
Show SMILES CN(C)C1CCN(CC1)c1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@@H](CCCNC(=O)c1ccc3c(Cl)cc(nc3c1)C1CC1)Cc1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 7


(Homo sapiens (Human))		BDBM581916
PNG
(WO2023003973, Compound 130)
Show SMILES CN(C)CCCOc1ccc2c(c1)ncn(CC1(O)CCN(CC1)C(=O)[C@@H](CCCNC(=O)c1ccc3c(Cl)c(cnc3c1)C(F)F)Cc1ccccc1)c2=O |r|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
WIPO WO2023003973
n/an/a<20n/an/an/an/an/an/a


TBA

Assay Description
Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...

Citation and Details

BindingDB Entry DOI: 10.7270/Q2GM8C50
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 1099 total )  |  Next  |  Last  >>
Jump to: